Cargando…

Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients

PURPOSE: Endocrine therapy is a standard treatment for hormone receptor-positive breast cancer, which accounts for 60%–75% of all breast cancer. Hormone receptor positivity is a prognostic and predictive biomarker in breast cancer. Approximately 50%–80% of breast cancer is also positive for androgen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yaewon, Min, Ahrum, Lee, Kyung-Hun, Ryu, Han Suk, Kim, Tae-Yong, Woo, Go-un, Suh, Koung Jin, Lee, Dae-Won, Lee, Han-Byoel, Moon, Hyeong-Gon, Han, Wonshik, Park, In Ae, Noh, Dong-Young, Im, Seock-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192742/ https://www.ncbi.nlm.nih.gov/pubmed/32395377 http://dx.doi.org/10.4048/jbc.2020.23.e28

Ejemplares similares

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2019)

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
por: Yang, Yaewon, et al.
Publicado: (2016)

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
por: Kim, Miso, et al.
Publicado: (2014)

Reduced proliferation in breast cancer cells contacting the neighboring adipocytes in human breast cancer tissues
por: Ryu, Han Suk, et al.
Publicado: (2015)

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
por: Beom, Seung Hoon, et al.
Publicado: (2017)

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
por: Kim, Seongyeong, et al.
Publicado: (2021)

Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
por: Choi, Mihong, et al.
Publicado: (2021)

Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism
por: Lee, Jiwoo, et al.
Publicado: (2017)

Erratum: A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
por: Kim, Yumi, et al.
Publicado: (2020)

A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
por: Kim, Yumi, et al.
Publicado: (2019)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
por: Kim, Jung Sun, et al.
Publicado: (2022)

Intensity of metastasis screening and survival outcomes in patients with breast cancer
por: Cheun, Jong-Ho, et al.
Publicado: (2021)

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response
por: Min, Ahrum, et al.
Publicado: (2020)

Life-Threatening Hematoma in an Elderly Breast Cancer Patient Undergoing Chemotherapy
por: Shin, Ik Beom, et al.
Publicado: (2023)

The Emotional Status, Attitudes in Decision-Making Process, and Their Impact on Surgical Choices in Korean Breast Cancer Patients
por: Jeon, Sook Young, et al.
Publicado: (2021)

Unique Features of Young Age Breast Cancer and Its Management
por: Lee, Han-Byoel, et al.
Publicado: (2014)

PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
por: Min, Ahrum, et al.
Publicado: (2020)

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
por: Lee, Eun-Shin, et al.
Publicado: (2016)

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
por: Lee, Ho-chang, et al.
Publicado: (2013)

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
por: Kim, Min Kyoon, et al.
Publicado: (2015)

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer
por: Ha, Dong-Hyeon, et al.
Publicado: (2020)

The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities
por: Han, Jaihong, et al.
Publicado: (2017)

Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer
por: Kang, Young-Joon, et al.
Publicado: (2019)

Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022)

The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers
por: Moon, Hyeong-Gon, et al.
Publicado: (2015)

NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis
por: Yoon, So-Hyun, et al.
Publicado: (2020)

Oncologic outcomes after immediate breast reconstruction following mastectomy: comparison of implant and flap using propensity score matching
por: Ha, Jeong Hyun, et al.
Publicado: (2020)

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
por: Suh, Koung Jin, et al.
Publicado: (2017)

Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
por: Lim, Changjin, et al.
Publicado: (2023)

Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence
por: Park, Soojin, et al.
Publicado: (2015)

Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis
por: Shin, Hee-Chul, et al.
Publicado: (2016)

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
por: Shin, Hee-Chul, et al.
Publicado: (2020)

Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related Lymphedema
por: Kim, Hong-Kyu, et al.
Publicado: (2021)

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
por: Lee, June Koo, et al.
Publicado: (2013)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data
por: Choi, Sung Hyouk, et al.
Publicado: (2020)

Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation
por: Kang, Eunji, et al.
Publicado: (2023)

Reliability of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Han, Ahram, et al.
Publicado: (2013)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
por: Lee, Kyung-Hun, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_23nir40hgi6pv8mgimp8c7mf9q